SLE mortality in an oriental population

Lupus

Volumn 6, Issue 1, 1997, Pages 27-31

  Koh, E T ^a   Seow, A ^b   Leong, K H ^a   Chng, H H ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Mortality; Oriental; Pulmonary haemorrhage; Systemic lupus erythematosus; Thrombocytopenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DISEASE; CANCER; CAUSE OF DEATH; DISEASE DURATION; FEMALE; HUMAN; INFECTION; LUNG EMBOLISM; LUNG HEMORRHAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

EID: 0031035685     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600104     Document Type: Article

References (36)

1. Merrell M, Shulman LE. Determination of prognosis in chronic disease illustrated by systemic lupus erythematosus. J Chronic Dis 1955; 1: 12-32.
2. Kellum RE, Hasericke JR. Systemic lupus erythematosus: A statistical evaluation of mortality based on a consecutive series of 299 patients. Arch Intern Med 1964; 113: 200-207.
3. Estes D, Christian C. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971; 50: 85-95.
4. Urowitz MB et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221-225.
5. Wallace DJ et al. Systemic lupus erythematosus: survival patterns: experience with 609 patients. JAMA 1981; 245: 934-938.
6. Ginzler EM et al. . A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25(6): 601-611.
7. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine (Baltimore) 1989; 68(3): 141-150.
8. Stafford-Brady F, Urowitz MB, Gladman DD Lupus retinopathy: patterns, associations and prognosis. Arthritis Rheum 1988; 31: 1105-1110.
9. Swaak AJG et al. Systemic lupus erythematosus: I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 447-454.
10. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in Systemic Lupus Erythematosus: Negative impact of increasing age at onset, black race and thrombocytopenia as well as causes of death. Arthritis Rheum 1990; 33(1): 37-48.
11. Gripenberg M, Helve T. Outcome of systemic lupus erythematosus: A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determination. Scand J Rheumatol 1991; 20: 104-109.
12. Pistiner M et al. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 1991; 21: 55-64.
13. Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum 1991; 21: 73-80.
14. Gladman DD. Prognosis of systemic lupus erythematosus and the factors that affect it. Curr Opin Rheumatol 1992; 4: 681-687.
15. Kumar A et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol Int 1992; 12: 107-109.
16. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985; 55(216): 87-98.
17. Ginzler EM, Schorn K. Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 67-78.
18. Ward MM, Pyun E, Studenski S. Causes of death in Systemic Lupus Erythematosus. Long term follow up of an inception cohort. Arthritis Rheum 1995; 38(10): 1492-1499.
19. Formiga Perez F et al. Infection and systemic lupus erythematosus: analysis of a series of 145 patients. Revista Clinica Espanola 1993; 193(3): 105-109.
20. Massardo L et al. Infections in systemic lupus erythematosus. Revista Medica de Chile 1991; 119(10): 1115-1122.
21. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: a review of hospitalised patients. J Rheum 1991; 18(8): 1180-1184.
22. Cohen MG, Li EK. Mortality in systemic lupus erythematosus, active disease is the most important factor. Aust NZ J Med 1992; 22(11): 5-8.
23. Studenski S et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987; 3012: 1326-1332.
24. Kaslow RA. High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum 1982; 25(4): 414-418.
25. Samanta A et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50(7): 490-492.
26. Dubois EL et al. Duration and death in SLE: An analysis of 249 cases. JAMA 1974; 227: 1399-1402.
27. Ward MM, Pyun E, Studenski S. Long term survival in systemic lupus crythematosus. Arthritis Rheum 1995; 38(2): 274-283.
28. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
29. Lee SS, Li CS, Li PCK. Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993; 2: 105-109.
30. Massardo L et al. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24(1): 1-11.
31. Nossent JC, Swaak AJG. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991, 80: 605-612.
32. Boey ML, Ng SC, Feng PH Mortality of orientals with systemic lupus erythematosus - a reappraisal. Singapore Med J 1987; 28(4): 318-320.
33. Petri M et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519.
34. Drenkard C et al. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheum 1994; 21(6): 1067-1072.
35. Pattersson T et al. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 437-439.
36. Canoso JJ, Cohen AS. Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 1974; 17: 383-390.